|
| Cotonou (our study) 2019 | Abidjan (Lokrou) 1992 | Ouagadougou (Drabo) 1996 | Senegal (Wade) 1999 | Congo Brazzaville (Nkoua) 2000 | Ouagadougou (Niakara) 2000 | Togo (Akossou) 2001 | Bobo Dioulasso (Yaméogo) 2012 | Senegal (Diédhiou) 2017 |
| Duration | 5 ans | 4 ans | 4 ans | 3 ans | 9 ans | 6 ans | 4 ans | 1 an | 4 ans |
| Number of case | 10 | 7 | 10 | 16 | 20 | 32 | 30 | 14 | 150 |
| Prevalence (%) | 13.88 | 14 | 22.2 | 10.52 | 12.6 | - | 36.58 | 33.3 | 9.8 |
| Mean-age (years) | 50.9 | 41.14 | 44 | 48 | 43 | 43.3 | - | 53.57 | 42.6 |
| Average duration (months) | 12 | 20.10 | - | - | - | - | - | - | 27 |
| Sex (dominance) | F | F | F | F | F | F | F | F | F |
| High BP background | 6 | - | 2 | 4 | 6 | - | - | 9 | 31.3% |
| Hyperthyroidism background | 1 | - | - | - | - | - | - | 3 | - |
| Heart disease background | 1 | - | - | 7 | - | 5 | - | - | 10% |
| Aetiology - Multinodular goiter - Basedow’s disease - Toxic adenoma - Thyroid cancer |
5 5 - - |
- - - - |
4 4 2 - |
2 9 1 - |
8 8 2 2 |
- - - - |
3 25 2
|
Not fin - 1
|
- - 18% - |
| Heart failure | 10 | 3 | 3 | 12 | 19 | 22 | 57.14% | 14 | 62% |
| Complete arrhytmia by atrial fibrillation | 6 | 2 | 3 | 9 | 7 | 13 | 28.57% | 8 | 38% |
| Coronary artery disease | 1 | 3 | 2 | - | - | - | 21.43% | 6 | 8% |
| Therapeutics measures - Synthetized antithyroids - Dietary and hygienics procedures - Diuretics ans cardiac glycosides - βeta-blockers - Anticoagulation treatment - Nitrates - Converting enzyme inhibitors - Calcium antagonist - Platelets aggregation inhibitors |
10 10 9 4 9 - 6 1 - |
Yes Yes Yes Yes - - - - - |
9 - - - - - - - - |
Yes - - - - - - - - |
Yes - - - - - - - - |
Yes Yes 22 10 22 - - - - |
Yes Yes Yes Yes - Yes Yes Yes
|
Yes Yes Yes Yes
- Yes Yes Yes |
Yes Yes Yes Yes - - - - - |
| Surgery | - | - | 4 | - | - | - | 1 | - | - |
| Average hospital stay | 7 jrs | - | - | - | - | 18.3 | - | 23.57 | - |
| Evolution - Positive - Death |
10 - |
- - |
- 1 |
- - |
- - |
9.7 1 |
29 1 |
- 1 |
- - |